UNVERIFIEDSingle SourceSTAT+: Baby KJ scientists hit speed bump in quest to scale custom gene editorStat News|3/31/2026
UNVERIFIEDSingle SourceSTAT+: FDA approves Rocket gene therapy for rare immune disorderStat News|3/27/2026
LINDYsurvived 9 daysSTAT+: FDA approves Denali Therapeutics drug for Hunter syndromeStat News|3/25/2026
UNVERIFIEDSingle SourceSTAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugsStat News|3/25/2026
UNVERIFIEDSingle SourceSTAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad eraStat News|3/19/2026
UNVERIFIEDSingle SourceThe FDA, urged to avoid controversy, creates a new headache with attack against UniQureStat News|3/6/2026
UNVERIFIEDSingle SourceSTAT+: The extremism of the FDA’s Marks and Prasad has come with costsStat News|3/5/2026
UNVERIFIEDSingle SourceSTAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trialStat News|3/3/2026
UNVERIFIEDSingle SourceSTAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDAStat News|3/2/2026
UNVERIFIEDSingle SourceOpinion: I’m a rare disease mom, and I finally have new hope for my son’s futureStat News|2/27/2026
UNVERIFIEDSingle SourceSTAT+: A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDAStat News|2/25/2026
UNVERIFIEDSingle SourceSTAT+: FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications Stat News|2/23/2026
UNVERIFIEDSingle SourceSTAT+: BridgeBio drug for genetic cause of dwarfism succeeds in key studyStat News|2/12/2026
UNVERIFIEDSingle SourceOpinion: My granddaughter has a rare disease. But clinical trials often exclude patients like herStat News|2/11/2026
UNVERIFIEDSingle SourceSTAT+: FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concernsStat News|1/26/2026